![Hiroki Narita](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroki Narita
Director/Board Member at Cardio, Inc.
Hiroki Narita active positions
Companies | Position | Start | End |
---|---|---|---|
Cardio, Inc. | Director/Board Member | 2009-07-14 | - |
Daiwa Corporate Investment Co., Ltd.
![]() Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Private Equity Investor | 2022-03-31 | - |
Career history of Hiroki Narita
Former positions of Hiroki Narita
Companies | Position | Start | End |
---|---|---|---|
RAQUALIA PHARMA INC. | Director/Board Member | 2011-07-13 | 2011-10-30 |
TMRC Co. Ltd.
![]() TMRC Co. Ltd. Medical/Nursing ServicesHealth Services TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan. | Director/Board Member | 2011-07-13 | - |
Daiwa SMBC Capital Co., Ltd.
![]() Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance The Group's principal activity is the venture capital operation and financing. The operations are carried out through the following divisions: Investment division deals with investment in venture business of domestic and overseas companies; establishing, operation and management of assets of investment partnerships and Financing division deals with loans, leasing, and other financial services. | Corporate Officer/Principal | - | - |
RIBOMIC INC. | Director/Board Member | 2009-07-14 | - |
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Director/Board Member | 2006-11-30 | - |
Training of Hiroki Narita
Aoyama Gakuin University | Undergraduate Degree |
Statistics
International
Japan | 8 |
United States | 2 |
Operational
Director/Board Member | 5 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
RIBOMIC INC. | Health Technology |
RAQUALIA PHARMA INC. | Health Technology |
Private companies | 5 |
---|---|
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Daiwa SMBC Capital Co., Ltd.
![]() Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance The Group's principal activity is the venture capital operation and financing. The operations are carried out through the following divisions: Investment division deals with investment in venture business of domestic and overseas companies; establishing, operation and management of assets of investment partnerships and Financing division deals with loans, leasing, and other financial services. | Finance |
Cardio, Inc. | |
TMRC Co. Ltd.
![]() TMRC Co. Ltd. Medical/Nursing ServicesHealth Services TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan. | Health Services |
Daiwa Corporate Investment Co., Ltd.
![]() Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Finance |
- Stock Market
- Insiders
- Hiroki Narita
- Experience